Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Tofacitinib may help treat severe hair loss, but more research is needed.

5 alpha-reductase inhibitors, like finasteride, are used to treat conditions like prostate issues and skin disorders.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

2′‐Fucosyllactose reduces hair loss and promotes hair growth in mice.

Folliculin helps regulate energy and nutrient sensing, impacting Birt–Hogg–Dubé syndrome.

Flutamide helps with prostate cancer and some skin conditions but can harm the liver.

New treatments for hair loss show promise, but require more research on long-term effects and proper dosing.

Finasteride affects UGT1A4 enzyme, but not enough to cause issues when combined with other drugs.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

A new nanocage system protects hair cells and reduces hearing loss effectively.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

HDAC inhibitors help brain cells grow and improve brain function.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.